These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33191403)

  • 1. Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome.
    Castagna L; Pagliardini T; Bramanti S; Schiano de Colella JM; Montes de Oca C; Bouabdallah R; Mariotti J; Fürst S; Granata A; De Philippis C; Harbi S; Sarina B; Legrand F; Maisano V; Weiller PJ; Chabannon C; Carlo-Stella C; Santoro A; Blaise D; Devillier R
    Bone Marrow Transplant; 2021 Apr; 56(4):883-889. PubMed ID: 33191403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
    J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center Analysis.
    Srinivasan A; Raffa E; Wall DA; Schechter T; Ali M; Chopra Y; Kung R; Chiang KY; Krueger J
    Transplant Cell Ther; 2022 Mar; 28(3):158.e1-158.e9. PubMed ID: 34838785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploidentical stem cell transplantation vs matched unrelated donor transplantation in adults with hematologic malignancies: a systematic review and meta-analysis.
    Ma L; Han X; Jiang S; Meng Q; Zhang L; Bao H
    Hematology; 2020 Dec; 25(1):356-365. PubMed ID: 33054609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
    Sahebi F; Eikema DJ; Koster L; Kroger N; Meijer E; van Doesum JA; Rovira M; Koc Y; Angelucci E; Blaise D; Sammassimo S; McDonald A; Arroyo CH; Sanchez JF; Forcade E; Castagna L; Stölzel F; Sanz J; Tischer J; Ciceri F; Valcarcel D; Proia A; Hayden PJ; Beksac M; Yakoub-Agha I; Schönland S
    Transplant Cell Ther; 2021 Dec; 27(12):999.e1-999.e10. PubMed ID: 34543768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics.
    Hamadani M; Ngoya M; Sureda A; Bashir Q; Litovich CA; Finel H; Chen Y; Boumendil A; Zain J; Castagna L; Cashen AF; Blaise D; Shadman M; Pastano R; Khimani F; Arat M; Dietrich S; Schmitz N; Glass B; Kharfan-Dabaja MA; Corradini P; Sauter CS; Montoto S; Kwon M; Herrera AF; Dreger P
    Blood Adv; 2022 Feb; 6(3):920-930. PubMed ID: 34861680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.
    Dodero A; Spina F; Narni F; Patriarca F; Cavattoni I; Benedetti F; Ciceri F; Baronciani D; Scimè R; Pogliani E; Rambaldi A; Bonifazi F; Dalto S; Bruno B; Corradini P
    Leukemia; 2012 Mar; 26(3):520-6. PubMed ID: 21904377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic stem cell transplantation from unmanipulated haploidentical donor and unrelated cord blood for T-cell lymphoma: a retrospective study from the Société Francophone de Greffe de Moelle et de Therapie Cellulaire.
    Cornillon J; Daguenet E; Tournilhac O; Blaise D; NGuyen S; Wallet HL; Chevallier P; Dulery R; Forcade E; Srour M; Bazarbachi A; Contentin N; Lioure B; Tinquaut F; Bulabois CE; Rubio MT; Robin M; Bay JO
    Bone Marrow Transplant; 2021 Nov; 56(11):2849-2856. PubMed ID: 34363006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients.
    Castagna L; Busca A; Bramanti S; Raiola Anna M; Malagola M; Ciceri F; Arcese W; Vallisa D; Patriarca F; Specchia G; Raimondi R; Devillier R; Furst S; Giordano L; Sarina B; Mariotti J; Olivieri A; Bouabdallah R; Carlo-Stella C; Rambaldi A; Santoro A; Corradini P; Bacigalupo A; Bonifazi F; Blaise D
    BMC Cancer; 2020 Nov; 20(1):1140. PubMed ID: 33234127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partially CD3
    Seif AE; Li Y; Monos DS; Heidemann SC; Aplenc R; Barrett DM; Casper JT; Freedman JL; Grupp SA; Margolis DA; Olson TS; Teachey DT; Keever-Taylor CA; Wang Y; Talano JM; Bunin NJ
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):493-501. PubMed ID: 31765697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher Total Body Irradiation Dose Intensity in Fludarabine/TBI-Based Reduced-Intensity Conditioning Regimen Is Associated with Inferior Survival in Non-Hodgkin Lymphoma Patients Undergoing Allogeneic Transplantation.
    Hamadani M; Khanal M; Ahn KW; Litovich C; Chow VA; Eghtedar A; Karmali R; Winter A; Fenske TS; Sauter C; Kharfan-Dabaja MA; Awan FT
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1099-1105. PubMed ID: 32165327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of non-first-degree related donors and first-degree related donors in haploidentical HSCT: a multi-centre retrospective analysis.
    Ye Y; Wang M; Malard F; Shi J; Lu Y; Ouyang G; Lan J; Tan Y; Zhao Y; Yu J; Lai X; Wu Y; Yang L; Gao F; Mohty M; Huang H; Luo Y
    Bone Marrow Transplant; 2021 Oct; 56(10):2567-2574. PubMed ID: 34031554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia.
    Bazarbachi A; Labopin M; Blaise D; Forcade E; Socié G; Berceanu A; Angelucci E; Bulabois CE; Kröger N; Rambaldi A; Ceballos P; Mielke S; El Cheikh J; Yakoub-Agha I; Savani B; Spyridonidis A; Nagler A; Mohty M
    Bone Marrow Transplant; 2021 Mar; 56(3):622-634. PubMed ID: 33020591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT.
    Shem-Tov N; Peczynski C; Labopin M; Itälä-Remes M; Blaise D; Labussière-Wallet H; Socié G; Kröger N; Mielke S; Afanasyev B; Chevallier P; Tischer J; Helbig G; Jindra P; Peric Z; Giebel S; Mohty M; Nagler A
    Leukemia; 2020 Jan; 34(1):283-292. PubMed ID: 31427719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.
    Wieduwilt MJ; Metheny L; Zhang MJ; Wang HL; Estrada-Merly N; Marks DI; Al-Homsi AS; Muffly L; Chao N; Rizzieri D; Gale RP; Gadalla SM; Cairo M; Mussetti A; Gore S; Bhatt VR; Patel SS; Michelis FV; Inamoto Y; Badawy SM; Copelan E; Palmisiano N; Kharfan-Dabaja MA; Lazarus HM; Ganguly S; Bredeson C; Diaz Perez MA; Cassaday R; Savani BN; Ballen K; Martino R; Wirk B; Bacher U; Aljurf M; Bashey A; Murthy HS; Yared JA; Aldoss I; Farhadfar N; Liu H; Abdel-Azim H; Waller EK; Solh M; Seftel MD; van der Poel M; Grunwald MR; Liesveld JL; Kamble RT; McGuirk J; Munker R; Cahn JY; Lee JW; Freytes CO; Krem MM; Winestone LE; Gergis U; Nathan S; Olsson RF; Verdonck LF; Sharma A; Ringdén O; Friend BD; Cerny J; Choe H; Chhabra S; Nishihori T; Seo S; George B; Baxter-Lowe LA; Hildebrandt GC; de Lima M; Litzow M; Kebriaei P; Hourigan CS; Abid MB; Weisdorf DJ; Saber W
    Blood Adv; 2022 Jan; 6(1):339-357. PubMed ID: 34547770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas.
    Montes de Oca C; Castagna L; De Philippis C; Bramanti S; Schiano JM; Pagliardini T; Collignon A; Harbi S; Mariotti J; Granata A; Maisano V; Furst S; Legrand F; Chabannon C; Carlo-Stella C; Santoro A; Blaise D; Devillier R
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2299-2305. PubMed ID: 32822845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical separation of cGvHD and GvL and better GvHD-free/relapse-free survival (GRFS) after unrelated cord blood transplantation for AML.
    Zheng CC; Zhu XY; Tang BL; Zhang XH; Zhang L; Geng LQ; Liu HL; Sun ZM
    Bone Marrow Transplant; 2017 Jan; 52(1):88-94. PubMed ID: 27376453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.